Dr. Michael Schlossmacher
Clinician Scientist, Ottawa Hospital Research Institute
Dr. Michael Schlossmacher is a clinician-scientist focused on improving the lives of patients with neurodegenerative diseases. After obtaining his M.D. degree at the University of Vienna, Austria, he pursed post-doctoral work on the molecular pathology of Alzheimer’s in the laboratory of Dr. Dennis J. Selkoe in Boston, Massachusetts. Then, following residency training in general medicine in Vienna, he completed adult neurology training and a clinical fellowship in movement disorders at Harvard Medical School. Since 2000, he has focused his research activities on Parkinson disease, dementia with Lewy bodies and multiple system atrophy. In 2006 and with support from the Canada Research Chair Program, Dr. Schlossmacher was recruited to the Ottawa Hospital Research Institute at the University of Ottawa, where he opened a new laboratory as a member of the Parkinson’s Research Consortium Ottawa. In 2012, he was named the Bhargava Research Chair in Neurodegeneration. The appointment was made possible through the generous support from Uttra and Sam Bhargava and their family members.